Protein Name |
Pfam ID |
Percentage of Identity (%) |
E value |
Mixed lineage kinase 1 (MAP3K9)
|
|
29.097 (87/299) |
9.51E-27 |
MST-1 protein kinase (STK4)
|
|
26.389 (76/288) |
6.60E-23 |
NIMA-related kinase 7 (NEK7)
|
|
26.071 (73/280) |
8.31E-23 |
Ribosomal protein S6 kinase alpha-2 (RSK2)
|
|
29.304 (80/273) |
3.72E-22 |
Serine/threonine-protein kinase 3 (STK3)
|
|
26.042 (75/288) |
9.67E-22 |
Omphalocele kinase 1 (NUAK1)
|
|
28.369 (80/282) |
1.52E-21 |
Ribosomal protein S6 kinase alpha-3 (RSK3)
|
|
29.197 (80/274) |
5.62E-21 |
Serine/threonine-protein kinase 24 (STK24)
|
|
26.642 (73/274) |
6.25E-21 |
NIMA-related kinase 6 (NEK6)
|
|
24.221 (70/289) |
1.14E-20 |
Ribosomal protein S6 kinase alpha-1 (RSK1)
|
|
28.571 (78/273) |
2.84E-20 |
Ribosomal protein S6 kinase alpha-6 (RSK6)
|
|
27.899 (77/276) |
3.06E-20 |
Microtubule affinity regulating kinase 3 (MARK3)
|
|
29.861 (86/288) |
1.99E-19 |
Serine/threonine-protein kinase 33 (STK33)
|
|
27.626 (71/257) |
3.68E-19 |
Serine/threonine-protein kinase 10 (STK10)
|
|
26.277 (72/274) |
3.82E-19 |
Oxidative stress responsive 1 (OXSR1)
|
|
23.567 (74/314) |
4.16E-19 |
Serine/threonine-protein kinase Nek5 (NEK5)
|
|
23.741 (66/278) |
6.08E-19 |
Ste-20-related kinase (STK39)
|
|
26.183 (83/317) |
6.12E-19 |
NUAK family SNF1-like kinase 2 (NUAK2)
|
|
27.046 (76/281) |
1.63E-18 |
Serine/threonine-protein kinase MARK1 (MARK1)
|
|
30.769 (72/234) |
2.36E-18 |
Unc-51 like kinase 3 (ULK3)
|
|
25.484 (79/310) |
2.39E-18 |
Testis-specific serine kinase 2 (TSSK2)
|
|
26.950 (76/282) |
4.05E-18 |
Salt-inducible kinase 2 (SIK2)
|
|
29.603 (82/277) |
4.20E-18 |
Leucine-rich repeat kinase 2 (LRRK2)
|
|
28.618 (87/304) |
7.25E-18 |
Testis-specific serine/threonine-protein kinase 6 (TSSK6)
|
|
26.923 (77/286) |
1.50E-17 |
Serine/threonine-protein kinase MARK2 (MARK2)
|
|
29.167 (84/288) |
1.62E-17 |
MAP/microtubule affinity-regulating kinase 4 (MARK4)
|
|
29.915 (70/234) |
1.67E-17 |
Putative 3-phosphoinositide-dependent protein kinase 2 (PDPK2P)
|
|
27.273 (66/242) |
2.32E-17 |
Serine/threonine-protein kinase 26 (STK26)
|
|
26.241 (74/282) |
2.74E-17 |
Phosphoinositide dependent protein kinase-1 (PDPK1)
|
|
28.340 (70/247) |
3.04E-17 |
STE20-related serine/threonine-protein kinase (SLK)
|
|
27.642 (68/246) |
3.16E-17 |
Serine/threonine-protein kinase 25 (STK25)
|
|
25.182 (69/274) |
3.86E-17 |
5'-AMP-activated protein kinase catalytic subunit alpha-1 (PRKAA1)
|
|
27.640 (89/322) |
4.22E-17 |
ERK activator kinase 2 (MEK2)
|
|
28.448 (66/232) |
4.81E-17 |
Salt-inducible kinase 1 (SIK1)
|
|
26.978 (75/278) |
6.88E-17 |
Putative serine/threonine-protein kinase SIK1B (SIK1B)
|
|
26.978 (75/278) |
7.39E-17 |
5'-AMP-activated protein kinase catalytic subunit alpha-2 (PRKAA2)
|
|
27.660 (78/282) |
1.20E-16 |
Fused homolog (STK36)
|
|
26.754 (61/228) |
1.84E-16 |
Aurora kinase A (AURKA)
|
|
23.209 (81/349) |
2.03E-16 |
Myosin-IIIb (MYO3B)
|
|
28.276 (82/290) |
3.19E-16 |
RAC-beta serine/threonine-protein kinase (AKT2)
|
|
26.296 (71/270) |
3.31E-16 |
PAK-2 protein kinase (PAK2)
|
|
22.601 (73/323) |
3.50E-16 |
Leucine-rich repeat serine/threonine-protein kinase 1 (LRRK1)
|
|
26.774 (83/310) |
3.59E-16 |
Protein kinase C theta (PRKCQ)
|
|
24.786 (87/351) |
5.30E-16 |
ERK activator kinase 1 (MEK1)
|
|
26.754 (61/228) |
8.74E-16 |
ERK activator kinase 5 (MAP2K5)
|
|
24.633 (84/341) |
1.10E-15 |
RAC-gamma serine/threonine-protein kinase (AKT3)
|
|
26.296 (71/270) |
1.23E-15 |
SPS1/STE20-related protein kinase YSK4 (YSK4)
|
|
25.714 (72/280) |
1.75E-15 |
Polo-like kinase 2 (PLK2)
|
|
23.129 (68/294) |
2.26E-15 |
RAC-alpha serine/threonine-protein kinase (AKT1)
|
|
25.364 (87/343) |
2.86E-15 |
Ribosomal protein S6 kinase beta-1 (S6K1)
|
|
27.542 (65/236) |
3.21E-15 |
Apoptosis signal-regulating kinase 1 (MAP3K5)
|
|
26.241 (74/282) |
5.13E-15 |
Serine/threonine-protein kinase ULK1 (ULK1)
|
|
27.413 (71/259) |
8.26E-15 |
cAMP-dependent protein kinase catalytic subunit beta (PRKACB)
|
|
24.232 (71/293) |
8.28E-15 |
Serine/threonine-protein kinase Sgk1 (SGK1)
|
|
24.375 (78/320) |
8.57E-15 |
Serine/threonine-protein kinase Nek8 (NEK8)
|
|
27.076 (75/277) |
8.76E-15 |
Calcium/calmodulin-dependent protein kinase type 1 (CAMK1)
|
|
26.280 (77/293) |
1.07E-14 |
SIK family kinase 3 (SIK3)
|
|
26.429 (74/280) |
1.19E-14 |
Testis-specific serine/threonine-protein kinase 1 (TSSK1B)
|
|
25.887 (73/282) |
1.35E-14 |
Serine/threonine-protein kinase PAK 3 (PAK3)
|
|
22.662 (63/278) |
1.55E-14 |
MAPK/ERK kinase kinase 1 (MAP3K1)
|
|
22.517 (68/302) |
1.58E-14 |
Myosin light chain kinase family member 4 (MYLK4)
|
|
24.749 (74/299) |
1.64E-14 |
Inhibitor of nuclear factor kappa-B kinase beta (IKKB)
|
|
25.316 (60/237) |
2.91E-14 |
Serine/threonine-protein kinase Nek3 (NEK3)
|
|
22.628 (62/274) |
3.02E-14 |
PAK-1 protein kinase (PAK1)
|
|
22.302 (62/278) |
3.20E-14 |
Cyclin-dependent kinase-like 4 (CDKL4)
|
|
25.322 (59/233) |
3.66E-14 |
cAMP-dependent protein kinase catalytic subunit alpha (PRKACA)
|
|
24.839 (77/310) |
3.94E-14 |
Serine/threonine-protein kinase Nek4 (NEK4)
|
|
24.407 (72/295) |
4.04E-14 |
Serine/threonine-protein kinase Nek11 (NEK11)
|
|
24.370 (58/238) |
4.28E-14 |
Serine/threonine-protein kinase PAK 5 (PAK5)
|
|
25.818 (71/275) |
4.73E-14 |
Serine/threonine-protein kinase ULK2 (ULK2)
|
|
24.903 (64/257) |
5.21E-14 |
Dual specificity mitogen-activated protein kinase kinase 4 (MAP2K4)
|
|
23.592 (88/373) |
5.36E-14 |
BR serine/threonine kinase 1 (BRSK1)
|
|
27.018 (77/285) |
5.90E-14 |
Myosin light chain kinase 3 (MYLK3)
|
|
28.261 (65/230) |
6.74E-14 |
Myosin light chain kinase 2 (MYLK2)
|
|
28.226 (70/248) |
7.11E-14 |
Myosin-IIIa (MYO3A)
|
|
26.298 (76/289) |
7.65E-14 |
PKC-delta-interacting protein kinase (RIPK4)
|
|
26.027 (76/292) |
8.60E-14 |
Cyclin-dependent kinase 2 (CDK2)
|
|
24.896 (60/241) |
1.09E-13 |
Doublecortin-like kinase 3 (DCLK3)
|
|
28.070 (80/285) |
1.10E-13 |
Protein kinase C delta (PRKCD)
|
|
25.899 (72/278) |
1.12E-13 |
Ribosomal protein S6 kinase beta-2 (RPS6KB2)
|
|
24.373 (68/279) |
1.20E-13 |
Cyclin-dependent kinase 6 (CDK6)
|
|
26.126 (58/222) |
1.25E-13 |
Serine/threonine-protein kinase NIM1 (NIM1K)
|
|
27.049 (66/244) |
1.26E-13 |
Serine/threonine-protein kinase PLK3 (PLK3)
|
|
21.543 (67/311) |
1.32E-13 |
Cyclin-dependent kinase 5 (CDK5)
|
|
24.903 (64/257) |
1.33E-13 |
Serine/threonine-protein kinase ICK (CILK1)
|
|
27.803 (62/223) |
1.67E-13 |
Serine/threonine-protein kinase STK11 (STK11)
|
|
23.490 (70/298) |
1.74E-13 |
cAMP-dependent protein kinase catalytic subunit gamma (PRKACG)
|
|
24.188 (67/277) |
1.82E-13 |
Protein kinase N2 (PKN2)
|
|
25.175 (72/286) |
2.20E-13 |
Calcium/calmodulin-dependent protein kinase type 1G (CAMK1G)
|
|
26.761 (76/284) |
2.50E-13 |
Mitogen-activated protein kinase kinase kinase 15 (MAP3K15)
|
|
25.887 (73/282) |
2.67E-13 |
Aurora kinase C (AURKC)
|
|
23.636 (65/275) |
2.72E-13 |
Serine/threonine-protein kinase Nek10 (NEK10)
|
|
24.038 (75/312) |
2.75E-13 |
Testis-specific serine/threonine-protein kinase 4 (TSSK4)
|
|
27.609 (82/297) |
3.33E-13 |
Serine/threonine-protein kinase PAK 6 (PAK6)
|
|
26.316 (60/228) |
3.35E-13 |
Cyclin-dependent kinase 3 (CDK3)
|
|
25.000 (56/224) |
3.88E-13 |
Polo-like kinase 4 (PLK4)
|
|
23.741 (66/278) |
3.96E-13 |
Maternal embryonic leucine zipper kinase (MELK)
|
|
25.735 (70/272) |
4.12E-13 |
NIMA-related kinase 2 (NEK2)
|
|
22.635 (67/296) |
4.13E-13 |
Serine/threonine-protein kinase Nek9 (NEK9)
|
|
22.837 (66/289) |
4.81E-13 |
Polo-like kinase 1 (PLK1)
|
|
23.214 (65/280) |
7.38E-13 |
Protein kinase N1 (PKN1)
|
|
26.740 (73/273) |
7.66E-13 |
Cyclin-dependent kinase-like 1 (CDKL1)
|
|
26.180 (61/233) |
7.82E-13 |
MEK kinase kinase 1 (MAP4K1)
|
|
23.322 (66/283) |
7.93E-13 |
Cyclin-dependent kinase-like 3 (CDKL3)
|
|
26.496 (62/234) |
8.52E-13 |
SNF-related serine/threonine-protein kinase (SNRK)
|
|
26.165 (73/279) |
9.22E-13 |
Cyclin-dependent kinase 17 (CDK17)
|
|
25.573 (67/262) |
1.00E-12 |
BR serine/threonine kinase 2 (BRSK2)
|
|
27.511 (63/229) |
1.12E-12 |
Death-associated protein kinase 1 (DAPK1)
|
|
24.825 (71/286) |
1.45E-12 |
Dual specificity mitogen-activated protein kinase kinase 3 (MAP2K3)
|
|
24.092 (73/303) |
1.49E-12 |
Cyclin-dependent kinase 7 (CDK7)
|
|
24.521 (64/261) |
2.59E-12 |
Calcium/calmodulin-dependent protein kinase type 1D (CAMK1D)
|
|
25.979 (73/281) |
2.98E-12 |
Checkpoint kinase-1 (CHK1)
|
|
28.311 (62/219) |
3.38E-12 |
Cyclin-dependent kinase 16 (CDK16)
|
|
24.615 (64/260) |
3.47E-12 |
Serine/threonine-protein kinase MAK (MAK)
|
|
25.225 (56/222) |
4.37E-12 |
NIMA-related kinase 1 (NEK1)
|
|
24.138 (70/290) |
4.43E-12 |
IL-1 receptor-associated kinase 1 (IRAK1)
|
|
27.039 (63/233) |
4.55E-12 |
Receptor-interacting serine/threonine-protein kinase 3 (RIPK3)
|
|
26.646 (85/319) |
6.26E-12 |
Dual specificity mitogen-activated protein kinase kinase 6 (MAP2K6)
|
|
23.843 (67/281) |
6.66E-12 |
PAK-4 protein kinase (PAK4)
|
|
23.000 (69/300) |
6.81E-12 |
Cyclin-dependent kinase 18 (CDK18)
|
|
26.522 (61/230) |
7.57E-12 |
Cyclin-dependent kinase 1 (CDK1)
|
|
26.840 (62/231) |
8.11E-12 |
Protein kinase G2 (PRKG2)
|
|
23.929 (67/280) |
8.24E-12 |
MAPK/ERK kinase kinase 3 (MAP3K3)
|
|
26.991 (61/226) |
1.07E-11 |
PDZ binding kinase (PBK)
|
|
23.308 (62/266) |
1.07E-11 |
Serine/threonine-protein kinase Sgk3 (SGK3)
|
|
25.751 (60/233) |
1.10E-11 |
Calcium/calmodulin-dependent protein kinase type 1B (PNCK)
|
|
26.007 (71/273) |
1.31E-11 |
Inhibitor of nuclear factor kappa-B kinase alpha (IKKA)
|
|
27.234 (64/235) |
1.34E-11 |
TRAF2 and NCK interacting kinase (TNIK)
|
|
25.368 (69/272) |
1.51E-11 |
MAPK/MAK/MRK overlapping kinase (MOK)
|
|
26.160 (62/237) |
1.57E-11 |
Cyclin-dependent kinase-like 5 (CDKL5)
|
|
23.404 (55/235) |
1.80E-11 |
Apoptosis signal-regulating kinase 2 (MAP3K6)
|
|
26.740 (73/273) |
1.87E-11 |
MAPK/ERK kinase kinase 2 (MAP3K2)
|
|
27.468 (64/233) |
2.24E-11 |
Calmodulin-dependent kinase II (CAMKK2)
|
|
24.380 (59/242) |
2.36E-11 |
Protein kinase C alpha (PRKCA)
|
|
23.985 (65/271) |
2.50E-11 |
Nik-related protein kinase (NRK)
|
|
24.214 (77/318) |
2.66E-11 |
Serine/threonine-protein kinase H1 (PSKH1)
|
|
26.860 (65/242) |
2.67E-11 |
G protein-coupled receptor kinase 6 (GRK6)
|
|
27.434 (62/226) |
3.24E-11 |
Death-associated protein kinase 3 (DAPK3)
|
|
23.776 (68/286) |
3.73E-11 |
Protein kinase C epsilon (PRKCE)
|
|
25.738 (61/237) |
3.82E-11 |
Doublecortin-like kinase 1 (DCLK1)
|
|
23.571 (66/280) |
3.87E-11 |
Death-associated protein kinase 2 (DAPK2)
|
|
25.630 (61/238) |
3.97E-11 |
Doublecortin-like kinase 2 (DCLK2)
|
|
23.973 (70/292) |
4.29E-11 |
Cyclin-dependent kinase 14 (CDK14)
|
|
24.590 (60/244) |
4.69E-11 |
Misshapen-like kinase 1 (MINK1)
|
|
25.000 (63/252) |
5.75E-11 |
Tyrosine-protein kinase EIF2AK2 (p68)
|
|
21.242 (65/306) |
6.26E-11 |
Serine/threonine-protein kinase Sgk2 (SGK2)
|
|
22.531 (73/324) |
6.47E-11 |
Testis-specific serine/threonine-protein kinase 3 (TSSK3)
|
|
25.664 (58/226) |
7.54E-11 |
Aurora kinase B (AURKB)
|
|
25.877 (59/228) |
7.58E-11 |
TAO kinase 3 (TAOK3)
|
|
24.549 (68/277) |
7.99E-11 |
Putative serine/threonine-protein kinase PRKY (PRKY)
|
|
23.276 (54/232) |
1.04E-10 |
Calcium/calmodulin-dependent protein kinase type IV (CAMK4)
|
|
28.125 (63/224) |
1.08E-10 |
G protein-coupled receptor kinase 5 (GRK5)
|
|
27.826 (64/230) |
1.11E-10 |
Proto-oncogene serine/threonine-protein kinase mos (MOS)
|
|
22.903 (71/310) |
1.57E-10 |
Serine/threonine-protein kinase TAO2 (TAOK2)
|
|
26.457 (59/223) |
1.77E-10 |
Myosin light kinase (MYLK)
|
|
25.000 (58/232) |
1.83E-10 |
cAMP-dependent protein kinase catalytic subunit PRKX (PRKX)
|
|
24.569 (57/232) |
1.85E-10 |
MAP kinase p38 (MAPK12)
|
|
26.316 (60/228) |
2.20E-10 |
Serine/threonine-protein kinase 32C (STK32C)
|
|
21.898 (60/274) |
2.23E-10 |
Serine/threonine-protein kinase 32A (STK32A)
|
|
20.807 (67/322) |
2.70E-10 |
TAO kinase 1 (TAOK1)
|
|
26.609 (62/233) |
2.77E-10 |
Serine/threonine-protein kinase H2 (PSKH2)
|
|
21.992 (53/241) |
2.84E-10 |
Serine/threonine-protein kinase 17B (STK17B)
|
|
24.925 (83/333) |
3.02E-10 |
Cyclin-dependent kinase-like 2 (CDKL2)
|
|
23.301 (72/309) |
3.33E-10 |
Cyclin-dependent kinase 13 (CDK13)
|
|
25.328 (58/229) |
3.79E-10 |
Protein kinase G1 (PRKG1)
|
|
22.509 (61/271) |
4.07E-10 |
Ribosomal protein S6 kinase alpha-4 (RPS6KA4)
|
|
22.840 (74/324) |
4.13E-10 |
Protein kinase C eta type (PRKCH)
|
|
23.711 (69/291) |
4.26E-10 |
Cyclin-dependent kinase 15 (CDK15)
|
|
24.188 (67/277) |
4.86E-10 |
Protein kinase C beta (PRKCB)
|
|
24.723 (67/271) |
5.77E-10 |
Stress-activated protein kinase 2b (p38 beta)
|
|
25.311 (61/241) |
5.87E-10 |
Cyclin-dependent kinase 12 (CDK12)
|
|
26.087 (60/230) |
6.57E-10 |
Rhodopsin kinase GRK1 (GRK1)
|
|
23.759 (67/282) |
6.81E-10 |
Serine/threonine-protein kinase SBK1 (SBK1)
|
|
25.862 (60/232) |
7.40E-10 |
Serine/threonine-protein kinase PDIK1L (PDIK1L)
|
|
24.060 (64/266) |
7.46E-10 |
Stress-activated protein kinase 2a (p38 alpha)
|
|
25.079 (79/315) |
9.86E-10 |
G protein-coupled receptor kinase 4 (GRK4)
|
|
26.106 (59/226) |
1.47E-09 |
Cytoplasmic DRAK1 (STK17A)
|
|
26.337 (64/243) |
1.49E-09 |
ERK activator kinase 7 (MAP2K7)
|
|
22.500 (72/320) |
1.62E-09 |
Yet another novel kinase 2 (STK32B)
|
|
20.606 (68/330) |
2.14E-09 |
Serine/threonine-protein kinase cot (COT)
|
|
23.129 (68/294) |
2.29E-09 |
Serine/threonine-protein kinase Chk2 (RAD53)
|
|
25.614 (73/285) |
2.40E-09 |
Extracellular signal-regulated kinase 5 (ERK5)
|
|
24.891 (57/229) |
2.48E-09 |
Cyclin-dependent kinase 4 (CDK4)
|
|
26.786 (60/224) |
2.52E-09 |
Cyclin-dependent kinase 20 (CDK20)
|
|
24.786 (58/234) |
2.71E-09 |
Ribosomal protein S6 kinase alpha-5 (RSK5)
|
|
25.417 (61/240) |
3.68E-09 |
Protein kinase N3 (PKN3)
|
|
25.523 (61/239) |
3.78E-09 |
MEK kinase kinase 2 (MAP4K2)
|
|
23.629 (56/237) |
4.33E-09 |
Cyclin-dependent kinase 9 (CDK9)
|
|
23.246 (53/228) |
4.62E-09 |
Hormonally up-regulated neu tumor-associated kinase (HUNK)
|
|
22.566 (51/226) |
5.23E-09 |
MEK kinase kinase 3 (MAP4K3)
|
|
22.105 (63/285) |
5.79E-09 |
Serine/threonine-protein kinase tousled-like 1 (TLK1)
|
|
26.425 (51/193) |
6.18E-09 |
Serine/threonine-protein kinase tousled-like 2 (TLK2)
|
|
25.523 (61/239) |
6.31E-09 |
Protein kinase C iota (PRKCI)
|
|
24.034 (56/233) |
6.82E-09 |
Serine/threonine-protein kinase pim-2 (PIM2)
|
|
26.712 (78/292) |
7.71E-09 |
MEK kinase kinase 4 (MAP4K4)
|
|
24.901 (63/253) |
8.10E-09 |
Microtubule-associated serine/threonine-protein kinase 3 (MAST3)
|
|
22.373 (66/295) |
8.77E-09 |
Obscurin (OBSCN)
|
|
24.771 (54/218) |
9.22E-09 |
Extracellular signal-regulated kinase 1 (ERK1)
|
|
24.658 (54/219) |
1.42E-08 |
Calcium/calmodulin-dependent protein kinase type II subunit alpha (CAMK2A)
|
|
24.082 (59/245) |
1.43E-08 |
Mitogen-activated protein kinase kinase kinase kinase 5 (MAP4K5)
|
|
22.456 (64/285) |
1.47E-08 |
TGF-beta receptor type I (TGFBR1)
|
|
23.100 (76/329) |
2.10E-08 |
MAPK/ERK kinase kinase 4 (MAP3K4)
|
|
21.147 (59/279) |
2.35E-08 |
Inhibitor of nuclear factor kappa-B kinase subunit epsilon (IKBKE)
|
|
24.797 (61/246) |
2.41E-08 |
Phosphorylase kinase testis gamma 2 (PHKG2)
|
|
25.974 (60/231) |
2.76E-08 |
Serine/threonine-protein kinase NLK (NLK)
|
|
34.409 (32/93) |
3.21E-08 |
Mitogen-activated protein kinase 13 (MAPK13)
|
|
25.000 (58/232) |
3.77E-08 |
Mitogen-activated protein kinase 4 (MAPK4)
|
|
26.872 (61/227) |
5.01E-08 |
TBC domain-containing protein kinase-like protein (TBCK)
|
|
22.509 (61/271) |
5.73E-08 |
Ribosomal protein S6 kinase-related protein (RSKR)
|
|
35.106 (33/94) |
5.74E-08 |
Peripheral plasma membrane protein CASK (CASK)
|
|
24.303 (61/251) |
5.84E-08 |
Extracellular signal-regulated kinase 2 (ERK2)
|
|
28.571 (30/105) |
7.34E-08 |
Serine/threonine-protein kinase 35 (STK35)
|
|
24.444 (77/315) |
9.13E-08 |
NF-kappa-B-activating kinase (TBK1)
|
|
25.620 (62/242) |
1.05E-07 |
Protein kinase C gamma (PRKCG)
|
|
26.761 (38/142) |
1.06E-07 |
Serine/threonine-protein kinase D2 (PRKD2)
|
|
25.551 (58/227) |
1.25E-07 |
Endoplasmic reticulum to nucleus signaling 1 (ERN1)
|
|
28.750 (46/160) |
1.35E-07 |
Activin receptor type IB (ACVR1B)
|
|
23.361 (57/244) |
1.36E-07 |
CaM-kinase IV kinase (CAMKK1)
|
|
28.758 (44/153) |
1.39E-07 |
Calcium/calmodulin-dependent protein kinase type II subunit gamma (CAMK2G)
|
|
23.105 (64/277) |
1.54E-07 |
Rhodopsin kinase GRK7 (GRK7)
|
|
23.451 (53/226) |
1.56E-07 |
Bone morphogenetic protein receptor (BMPR2)
|
|
24.633 (84/341) |
1.94E-07 |
Calcium/calmodulin-dependent protein kinase type II subunit beta (CAMK2B)
|
|
22.302 (62/278) |
2.35E-07 |
Mitogen-activated protein kinase 15 (MAPK15)
|
|
25.000 (61/244) |
2.36E-07 |
Protein kinase D (PRKD1)
|
|
23.904 (60/251) |
2.59E-07 |
Dual specificity protein kinase TTK (MPS1)
|
|
23.490 (35/149) |
3.08E-07 |
Eukaryotic translation initiation factor 2-alpha kinase 1 (EIF2AK1)
|
|
30.159 (38/126) |
3.36E-07 |
Striated muscle preferentially expressed protein kinase (SPEG)
|
|
24.464 (57/233) |
3.87E-07 |
Microtubule-associated serine/threonine-protein kinase 4 (MAST4)
|
|
22.488 (47/209) |
4.49E-07 |
Serine/threonine-protein kinase WNK1 (WNK1)
|
|
23.707 (55/232) |
4.57E-07 |
Microtubule-associated serine/threonine-protein kinase 2 (MAST2)
|
|
21.514 (54/251) |
4.71E-07 |
Serine/threonine-protein kinase pim-1 (PIM1)
|
|
27.273 (42/154) |
6.08E-07 |
Serine/threonine-protein kinase D3 (PRKD3)
|
|
24.889 (56/225) |
6.31E-07 |
Protein kinase C zeta (PRKCZ)
|
|
21.296 (69/324) |
7.13E-07 |
Microtubule-associated serine/threonine-protein kinase 1 (MAST1)
|
|
23.333 (49/210) |
7.30E-07 |
Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform (PHKG1)
|
|
25.248 (51/202) |
8.26E-07 |
Dual-specificity tyrosine-phosphorylation regulated kinase 3 (DYRK3)
|
|
36.538 (38/104) |
8.46E-07 |
Serine/threonine-protein kinase WNK4 (WNK4)
|
|
23.276 (54/232) |
9.11E-07 |
Wee1-like protein kinase 2 (WEE2)
|
|
26.667 (48/180) |
1.17E-06 |
Wee1-like protein kinase (WEE1)
|
|
23.000 (69/300) |
1.28E-06 |
Titin (TTN)
|
23.043 (53/230) |
1.49E-06 |
Calcium/calmodulin-dependent protein kinase type II subunit delta (CAMK2D)
|
|
22.857 (56/245) |
1.50E-06 |
PRKR-like endoplasmic reticulum kinase (PERK)
|
|
30.303 (30/99) |
1.58E-06 |
Mitogen-activated protein kinase 6 (MAPK6)
|
|
22.467 (51/227) |
1.92E-06 |
Cyclin-dependent kinase 11A (CDK11A)
|
|
22.523 (50/222) |
2.15E-06 |
MAPK-activated protein kinase 2 (MAPKAPK2)
|
|
27.072 (49/181) |
2.46E-06 |
Homeodomain-interacting protein kinase 4 (HIPK4)
|
|
25.424 (60/236) |
2.55E-06 |
WNK lysine-deficient protein kinase 3 (WNK3)
|
|
22.768 (51/224) |
3.43E-06 |
Glycogen synthase kinase-3 alpha (GSK-3A)
|
|
22.449 (55/245) |
4.35E-06 |
Cyclin-dependent kinase 19 (CDK19)
|
|
26.271 (62/236) |
4.68E-06 |
Cyclin-dependent kinase 8 (CDK8)
|
|
25.564 (68/266) |
5.14E-06 |
CaM kinase-like vesicle-associated protein (CAMKV)
|
|
24.000 (54/225) |
5.71E-06 |
Cyclin-G-associated kinase (GAK)
|
|
20.958 (70/334) |
5.79E-06 |
Anti-mullerian hormone II receptor (AMHR2)
|
|
23.926 (78/326) |
7.91E-06 |
Stress-activated protein kinase JNK3 (JNK3)
|
|
31.183 (29/93) |
9.14E-06 |
CDC-like kinase 1 (CLK1)
|
|
24.800 (62/250) |
9.45E-06 |
Cyclin-dependent kinase 11B (CDK11B)
|
|
22.523 (50/222) |
9.68E-06 |
Serine/threonine-protein kinase WNK2 (WNK2)
|
|
24.194 (45/186) |
9.81E-06 |
Serine/threonine-protein kinase greatwall (MASTL)
|
|
23.034 (41/178) |
1.19E-05 |
IL-1 receptor-associated kinase 3 (IRAK3)
|
|
21.702 (51/235) |
1.32E-05 |
Stress-activated protein kinase JNK1 (JNK1)
|
|
31.183 (29/93) |
1.37E-05 |
CDC-like kinase 2 (CLK2)
|
|
22.500 (54/240) |
1.42E-05 |
Stress-activated protein kinase JNK2 (JNK2)
|
|
31.183 (29/93) |
1.43E-05 |
Triple functional domain protein (TRIO)
|
|
24.123 (55/228) |
1.44E-05 |
Glycogen synthase kinase-3 beta (GSK-3B)
|
|
22.128 (52/235) |
1.68E-05 |
Casein kinase II alpha (CSNK2A1)
|
|
26.923 (28/104) |
1.99E-05 |
Dual-specificity tyrosine-phosphorylation regulated kinase 1A (DYRK1A)
|
|
26.087 (60/230) |
2.58E-05 |
Dual-specificity tyrosine-phosphorylation regulated kinase 2 (DYRK2)
|
|
33.645 (36/107) |
2.96E-05 |
Dual-specificity tyrosine-phosphorylation regulated kinase 1B (DYRK1B)
|
|
25.652 (59/230) |
3.52E-05 |
STE20-related kinase adapter protein alpha (STRADA)
|
|
22.222 (48/216) |
3.63E-05 |
PAS domain-containing serine/threonine-protein kinase (PASK)
|
|
25.532 (60/235) |
5.00E-05 |
Activin receptor type IIA (ACVR2A)
|
|
23.214 (52/224) |
5.04E-05 |
Rho-associated protein kinase 2 (ROCK2)
|
|
23.377 (54/231) |
5.26E-05 |
Cyclin-dependent kinase 10 (CDK10)
|
|
22.624 (50/221) |
5.45E-05 |
Citron Rho-interacting kinase (CIT)
|
|
24.275 (67/276) |
5.62E-05 |
Large tumor suppressor homolog 2 (LATS2)
|
|
21.033 (57/271) |
6.50E-05 |
Serine/threonine-protein kinase SBK2 (SBK2)
|
|
25.110 (57/227) |
6.78E-05 |
Casein kinase II subunit alpha 3 (CSNK2A3)
|
|
25.962 (27/104) |
7.16E-05 |
Homeodomain-interacting protein kinase 3 (HIPK3)
|
|
23.729 (56/236) |
7.40E-05 |
Serine/threonine-protein kinase 40 (STK40)
|
|
22.353 (38/170) |
1.00E-04 |
Rho-associated protein kinase 1 (ROCK1)
|
|
23.810 (55/231) |
1.04E-04 |
Serine/threonine kinase-like domain-containing protein STKLD1 (STKLD1)
|
|
25.466 (41/161) |
1.41E-04 |
Serine/threonine-protein kinase PRP4 homolog (PRPF4B)
|
|
25.820 (63/244) |
1.66E-04 |
Adaptor-associated kinase 1 (AAK1)
|
|
18.873 (67/355) |
1.96E-04 |
Serine/threonine-protein kinase NIK (MAP3K14)
|
|
23.077 (54/234) |
2.38E-04 |
CDC-like kinase 4 (CLK4)
|
|
24.481 (59/241) |
2.98E-04 |
BMP-2-inducible protein kinase (BMP2K)
|
|
20.968 (52/248) |
3.03E-04 |
Dual-specificity tyrosine-phosphorylation regulated kinase 4 (DYRK4)
|
|
28.972 (31/107) |
3.25E-04 |
Homeodomain interacting protein kinase 2 (HIPK2)
|
|
23.305 (55/236) |
3.52E-04 |
Serine/threonine-protein kinase/endoribonuclease IRE2 (ERN2)
|
|
25.773 (75/291) |
3.55E-04 |
Homeodomain-interacting protein kinase 1 (HIPK1)
|
|
22.619 (76/336) |
4.22E-04 |
Eukaryotic translation initiation factor 2-alpha kinase 4 (EIF2AK4)
|
|
25.325 (39/154) |
4.85E-04 |
Tribbles homolog 2 (TRIB2)
|
|
24.026 (37/154) |
4.91E-04 |
Serine/threonine-protein kinase LATS1 (LATS1)
|
|
21.965 (38/173) |
5.99E-04 |
Beta-adrenergic receptor kinase 1 (ADRBK1)
|
|
23.871 (37/155) |
7.64E-04 |
MAPK-activated protein kinase 3 (MAPKAPK3)
|
|
24.167 (29/120) |
1.00E-03 |
Serine/threonine-protein kinase Kist (UHMK1)
|
|
27.273 (33/121) |
1.00E-03 |
CDC-like kinase 3 (CLK3)
|
|
21.368 (50/234) |
1.00E-03 |
Interleukin-1 receptor-associated kinase-like 2 (IRAK2)
|
|
21.212 (49/231) |
1.00E-03 |
MAPK signal-integrating kinase 1 (MKNK1)
|
|
24.219 (62/256) |
2.00E-03 |
Casein kinase II alpha prime (CSNK2A2)
|
|
23.077 (24/104) |
4.00E-03 |
Activin receptor type IIB (ACVR2B)
|
|
25.000 (32/128) |
5.00E-03 |
Click to Show/Hide the Information of Human Similarity Proteins |